Correlation Between Nuvalent and Phathom Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Nuvalent and Phathom Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvalent and Phathom Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nuvalent and Phathom Pharmaceuticals, you can compare the effects of market volatilities on Nuvalent and Phathom Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvalent with a short position of Phathom Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvalent and Phathom Pharmaceuticals.

Diversification Opportunities for Nuvalent and Phathom Pharmaceuticals

0.23

Correlation Coefficient

Nuvalent  Phathom Pharmaceuticals

Modest diversification

The 3 months correlation between Nuvalent and Phathom is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Nuvalent and Phathom Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phathom Pharmaceuticals and Nuvalent is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvalent are associated (or correlated) with Phathom Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phathom Pharmaceuticals has no effect on the direction of Nuvalent i.e., Nuvalent and Phathom Pharmaceuticals go up and down completely randomly.

Pair Corralation between Nuvalent and Phathom Pharmaceuticals

Given the investment horizon of 90 days Nuvalent is expected to generate 0.7 times more return on investment than Phathom Pharmaceuticals. However, Nuvalent is 1.42 times less risky than Phathom Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Phathom Pharmaceuticals is currently generating about 0.01 per unit of risk. If you would invest  6,800  in Nuvalent on September 8, 2024 and sell it today you would earn a total of  2,631  from holding Nuvalent or generate 38.69% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Nuvalent  vs.  Phathom Pharmaceuticals

Nuvalent

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Nuvalent are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, Nuvalent may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Phathom Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Phathom Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Nuvalent and Phathom Pharmaceuticals

The main advantage of trading using opposite Nuvalent and Phathom Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvalent position performs unexpectedly, Phathom Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phathom Pharmaceuticals will offset losses from the drop in Phathom Pharmaceuticals' long position.

The idea behind Nuvalent and Phathom Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.